ExodusPoint Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-134,038
| Closed | -$139K | – | 1468 |
|
|
2024
Q3 | $139K | Buy |
+134,038
| New | +$139K | ﹤0.01% | 1374 |
|
|
2024
Q2 | – | Sell |
-16,211
| Closed | -$39K | – | 1439 |
|
|
2024
Q1 | $39K | Buy |
+16,211
| New | +$39K | ﹤0.01% | 1312 |
|
|
2023
Q2 | – | Sell |
-86,909
| Closed | -$594K | – | 1796 |
|
|
2023
Q1 | $594K | Buy |
86,909
+55,308
| +175% | +$378K | ﹤0.01% | 1196 |
|
|
2022
Q4 | $250K | Sell |
31,601
-112,000
| -78% | -$886K | ﹤0.01% | 1354 |
|
|
2022
Q3 | $1.38M | Buy |
+143,601
| New | +$1.38M | 0.02% | 931 |
|
|
2022
Q2 | – | Sell |
-50,968
| Closed | -$658K | – | 1935 |
|
|
2022
Q1 | $658K | Buy |
50,968
+30,645
| +151% | +$396K | 0.01% | 1321 |
|
|
2021
Q4 | $324K | Sell |
20,323
-6,756
| -25% | -$108K | ﹤0.01% | 1591 |
|
|
2021
Q3 | $435K | Buy |
+27,079
| New | +$435K | 0.01% | 1424 |
|
|
2021
Q2 | – | Sell |
-50,716
| Closed | -$741K | – | 2316 |
|
|
2021
Q1 | $741K | Buy |
+50,716
| New | +$741K | 0.01% | 1060 |
|
|
2020
Q4 | – | Sell |
-13,345
| Closed | -$245K | – | 1928 |
|
|
2020
Q3 | $245K | Buy |
+13,345
| New | +$245K | ﹤0.01% | 1327 |
|
|
2019
Q3 | – | Sell |
-104,978
| Closed | -$2.32M | – | 1328 |
|
|
2019
Q2 | $2.32M | Buy |
104,978
+67,916
| +183% | +$1.5M | 0.09% | 121 |
|
|
2019
Q1 | $506K | Buy |
+37,062
| New | +$506K | 0.04% | 325 |
|